Methods Enzymol. 2017;593:237-257. doi: 10.1016/bs.mie.2017.05.006. Epub 2017 Jul 3.
Abstract
Cannabidiol (CBD) is one of the most abundant components isolated from Cannabis sativa. However, CBD is a nonpsychotropic phytocannabinoid. In the last decade, there has been a growing interest in its therapeutic effects. This is why this natural product represents a lead structure for the development of new cannabinoid compounds. Even though chemistry of CBD has been explored for more than 30 years, the synthesis of only a few derivatives has been described. This chapter first reviews the synthetic methods for the preparation of CBD and derivatives. Then, it describes procedures for the synthesis of N-heterocyclic derivatives of CBD with, in particular, the preparation and structural characterization of 5-alkyl-2-(1H-pyrazol-3-yl)benzene-1,3-diol.
© 2017 Elsevier Inc. All rights reserved.
KEYWORDS:
Cannabidiol; Cannabidiol derivative; Cannabinoid; Structural modification; Synthesis
- PMID: 28750806
- DOI: 10.1016/bs.mie.2017.05.006